A novel culture environment for generating mature human dentritic cells from peripheral blood CD14+ cells

Anticancer Research

Volumn 21, Issue 2 A, 2001, Pages 1199-1206

  Tsiatas, M L ^a   Gritzapis, A D ^a   Cacoullos, N T ^a   Papadhimitriou, S I ^a   Baxevanis, C N ^a   Papamichail, M ^a  

^a SAINT SAVVAS HOSPITAL   (Greece)

Author keywords

Anti CD3 monoclonal antibody; Dendritic cells; IL 10; IL 12; T cells

Indexed keywords

CD14 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4;

ADULT; AGED; ARTICLE; CANCER IMMUNOLOGY; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE CULTURE; LYMPHOCYTE PROLIFERATION; MALE; MIXED LYMPHOCYTE REACTION; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ANTIGENS, CD14; ANTIGENS, CD3; BREAST NEOPLASMS; CD4-POSITIVE T-LYMPHOCYTES; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; FEMALE; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOPHENOTYPING; LEUKOCYTES, MONONUCLEAR; LUNG NEOPLASMS; MALE; MIDDLE AGED; OVARIAN NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0035017424     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Presentation of exogenous protein antigens by dendritic cells to T cell clones
2. Origin, maturation and antigen processing function of dendritic cells
3. Generation of antigen specific CD8+ CTLs from naive precursors
4. + TNF-α
5. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha
6. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability
7. Type I IFNs enhance the terminal differentiation of dendritic cells
8. A monocyte conditioned medium is more effective than defined cytokines in mediating the terminal maturation of human dendritic cells
9. Long-term treatment of malignant gliomas with intramuscularly administered polynosinic-polycytidylic acid stabilized with polylisine and carboxymethylcellulose: An open pilot study
10. Polyriboinosinic polyribocytidylic acid (Poly (I:C)) induces stable maturation of functionally active human dendritic cells
11. Maturation, activation and protection of dendritic cells induced by double-stranded RNA
12. Induction of antitumor lymphocytes in cancer patients after brief exposure to supernatants from cultures of anti-CD3-stimulated allogeneic lymphocytes
13. Increased generation of autologous tumor-reactive lymphocytes by anti-CD3 monoclonal antibody and prothymosin-α
14. Antigen-presenting cells pulsed with unfractionated tumor-derived peptides are potent tumor vaccines
15. Enhanced human lymphokine-activated killer cell function after brief exposure to granulocyte-macrophage-colony stimulating factor
16. The role of CD4+ T cell responses on antitumor immunity
17. Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application
18. Interleukin-12: A cytokine produced by antigen presenting cell with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes
19. Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adoptive immunity
20. Interleukin-18 binding protein: A novel modulator of the Th1 cytokine response
21. A role for endogenous transforming growth factor 1 in Langerhans cell biology: The skin of transforming growth factor 1 null mice is devoid of epidermal Langerhans cells
22. Interleukin-12: A cytokine at the interface of inflammation and immunity
23. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10 and IL-4-deficient and transgenic mice
24. Dendritic cells obtained from peripheral blood precursors in the presence of PGE2, promote Th2 responses